| Literature DB >> 28441973 |
Annette Robertsen1,2, Reidun Førde3, Nils Oddvar Skaga4,5, Eirik Helseth6,7.
Abstract
BACKGROUND: Treatment-limiting decisions (TLD) for severe traumatic brain injury (sTBI) have been sparsely studied. This study determine prevalence, main reason for, categories and timing of TLDs in a Norwegian regional trauma setting.Entities:
Keywords: Decision-making; Futility; Potentially inappropriate treatment; Traumatic brain injury; Withholding treatment
Mesh:
Year: 2017 PMID: 28441973 PMCID: PMC5405474 DOI: 10.1186/s13049-017-0385-x
Source DB: PubMed Journal: Scand J Trauma Resusc Emerg Med ISSN: 1757-7241 Impact factor: 2.953
Cohort characteristics (N = 579). Comparison of patients with and without TLDs
| Cohort characteristics | TLD-group ( | No TLD-group ( |
| |
|---|---|---|---|---|
| Sex and age | Male | 75 (74%) | 350 (73%) | 0.831 |
| Female | 26 (26%) | 128 (27%) | ||
| Mean age (range) | 60.8 (18–97) | 51.3 (18–95) | <0.001 | |
| Mechanism of injury | Transport | 23 (23%) | 122 (26%) | 0.562 |
| Fall | 65 (64%) | 274 (57%) | 0.192 | |
| Violence | 3 (3%) | 50 (10.5%) | 0.018 | |
| Self-inflicted | 8 (8%) | 8 (2%) | 0.001 | |
| Sport | 3 (3%) | 27 (6%) | 0.270 | |
| Other | 1 (1%) | 11 (2%) | 0.401 | |
| GCS* | GCS 3 -8 | 70 (69%) | 110 (23%) | <0.001 |
| GCS >8 | 31 (31%) | 368 (77%) | ||
| Injury severity | AIS* head max mean | 4.8 | 4.4 | <0.001 |
| ISS* median (range) | 30 (17–75) | 26 (16–75) | <0.001 | |
| NISS* median (range) | 57 (18–75) | 38 (16–75) | <0.001 | |
| Intensive care | ICU* admission | 86 (85%) | 409 (86%) | 0.914 |
| Ventilator days median (range) | 6.3 (1–51) | 11 (1–45) | <0.001 | |
| Neurosurgery | ICP* monitor | 31 (31%) | 159 (33%) | 0.617 |
| EVD* | 17 (17%) | 21 (4%) | <0.001 | |
| Craniotomy | 18 (18%) | 113 (25%) | 0.240 | |
| Hemicraniectomy | 9 (9%) | 17 (4%) | 0.018 | |
| Hospital LOS* | Median (range) | 3 (1–51) | 6 (1–56) | 0.04 |
| Discharge destination | Home | 0 (0%) | 128 (26.8%) | <0.001 |
| Rehabilitation | 2 (2%) | 88 (18.4%) | ||
| Ward other hospital | 7 (7%) | 148 (31%) | ||
| ICU other hospital | 12 (12%) | 90 (18.8%) | ||
| Nursing home | 6 (6%) | 19 (4%) | ||
| Died at OUH* | 74 (73%) | 5 (1%) | ||
*See abbreviations
Futile or potentially inappropriate treatment in the 101 patients
| N= | ||
|---|---|---|
| Futile | Physiological stabilization in the emergency room (ER) not possible | 8 |
| Early recognition of futility (within the time frame of primary, secondary and tertiary trauma survey but after the ER) | 42 | |
| Later recognition of futility. Physiological goals could not be accomplished. Deteriorating, e.g., refractory intracranial pressure occurred after a transient initial stabilization. | 9 | |
| Potentially inappropriate | Treatment started, but it might not be possible to accomplish improvement or stabilization. An effect might be accomplished but may not be wanted. | 42 |
Categories of treatment-limiting decisions in the 101 patients
| Categories of treatment-limiting decisions (TLD) | N= | |
|---|---|---|
| Withhold | Access to ICU | 7 |
| Organ support (ventilator, vasopressor, dialysis) | 10 | |
| Neurosurgery | 52 | |
| DNR order | 44 | |
| No escalation of treatment | 19 | |
| Withdraw | ICP targeted treatment | 23 |
| Organ support | 44 | |
| Nutrition by PEG or nasogastric tube | 0 | |
* One patient may have several TLDs
Chart documentation of key elements of the decision-making process for TLD. One patient may have several documented aspects
| Documented key elements of decision-making process for TDL N= | |
|---|---|
| Prognostic statements | 91 |
| Family meetings | 89 |
| Advanced directives | 0 |
| Notifications of patient preferences regarding withholding or withdrawing of life-sustaining treatment based on communication with family | 7 |
| Notification of patient’s preferences regarding organ donation (only asked for in cases progressing towards brain death). Brain death occurred in 26 patients. | 24 |
| Multi-disciplinary discussions prior to decision | 92 |
| Documented rationale for TLD (treatment-limiting decisions) | 100 |
| Request by family to withhold/withdraw when physician recommended continued treatment | 2 |
| Request by family for continued treatment when physician recommended to WH/WD | 2 |
| Major conflict between treatment team and families regarding WH/WD | 0 |
| Involvement of clinical ethics committee (CEC) | 0 |
| Involvement of palliative care consult | 0 |
Cohort mortality rates
| TLD-group ( | No TLD-group ( | All ( | |
|---|---|---|---|
| Emergency room mortality | 8 (8%) | 4 (<1%) | 12 (2%) |
| In-hospital mortality at OUH | 74 (73%) | 5 (1%) | 79 (13.6%) |
| 30-day mortality | 83 (82%) | 10 (2%) | 93 (16%) |
| 2-year mortality | 94 (93%) | 40 (8%) | 134 (23%) |
Fig. 1Kaplan-Meier survival plot in days for patients with TLD and without TLD